Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;43(6):2119-2128.
doi: 10.1007/s10792-023-02695-1. Epub 2023 Apr 4.

Effect of adalimumab on experimental corneal neovascularization model

Dilek Özkaya  1 , Umut Karaca  2 , Gülşah Usta Sofu  2 , Mehtap Savran  3 , Meltem Özgöçmen  4 , Alper Ertuğrul  2
Affiliations

Effect of adalimumab on experimental corneal neovascularization model

Dilek Özkaya et al. Int Ophthalmol. 2023 Jun.

Abstract

Purpose: To evaluate the efficacy of adalimumab (ADA) on inhibition of experimental corneal neovascularization (CNV) and compare the outcomes with bevacizumab (BEVA).

Methods: Twenty-four female Winstar rats (48 eyes) were used. Silver/Potassium Nitrate sticks were used for creating CNV. Forty-eight eyes of the rats were separated into 6 groups. The eyes which only NaCl was injected subconjunctivally (SC) formed Group-1. The eyes which CNV was created and NaCl, BEVA (2.5 mg/0.05 mL), ADA (2.5 mg/0.05 mL), respectively, were injected SC formed group-2, 3 and 4. The eyes which only BEVA and ADA, respectively, were injected SC formed group-5 and 6. Five days later the animals were sacrificed. Hematoxylin and eosin staining, Masson trichrome staining, Vascular endothelial growth factor (VEGF), and Platelet-derived growth factor (PDGF) antibodies were performed.

Results: Histochemical results showed that there was no histopathological finding in group-1, 5, and 6. Collagen fiber irregularity was observed in group-2 and there was a significant improvement in collagen fiber irregularity in group-3 and 4. Collagen fiber proliferation was higher in group-2 than in group-3 and 4. VEGF and PDGF stainings were not observed in group-1, 5, and 6. VEGF and PDGF stainings were observed in group-2 and significantly decreased in group-3 and 4 compared to group-2. ADA was found to be superior to BEVA in terms of decreasing VEGF staining.

Conclusion: Both BEVA and ADA were effective in inhibiting CNV. Subconjunctival ADA seems to be more effective than BEVA in terms of inhibiting VEGF expression. Further experimental studies about ADA and BEVA are needed.

Keywords: Adalimumab; Bevacizumab; Corneal neovascularization; Vascular endothelial growth factor.

PubMed Disclaimer

References

    1. Al-Debasi T, Al-Bekairy A, Al-Katheri A et al (2017) Topical versus subconjunctival anti-vascular endothelial growth factor (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol 31:99–105 - DOI - PubMed - PMC
    1. Azar DT (2006) Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol 104:264–302
    1. Beebe DC (2008) Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol 19:125–133 - DOI - PubMed
    1. Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: An epidemiologic review. Surv Ophthalmol 43:245–269 - DOI - PubMed
    1. Kenyon BM, Voest EE, Chen CC et al (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol 37:1625–1632

MeSH terms

LinkOut - more resources